Biotech giant CSL’s $757m for potential Dutch buy revealed
MELBOURNE: ASX heavyweight CSL, under-scrutiny over plans to cut 3000 jobs and spin-out its Seqirus
MELBOURNE: ASX heavyweight CSL, under-scrutiny over plans to cut 3000 jobs and spin-out its Seqirus